Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 317
interventional 279
Observational 31
Registry 7

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 130
Procedure 22
Drug|Other 20
Device 19
Biological 12
Drug|Procedure 11
Biological|Drug 9
Device|Drug 8
Drug|Radiation 7
Radiation 5
Drug|placebo 4
Other 4
Combination Product|Drug 3
Diagnostic Test 3
Drug|Other|Procedure 3
Behavioral 2
Behavioral|Other 2
Biological|Drug|Other 2
Biological|Procedure 2
Dietary Supplement 2
Biological|Other 1
Biological|placebo 1
Biological|Radiation 1
Device|Other 1
Drug|Genetic|Other 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Other|Procedure|Radiation 1
Other|Procedure 1
Other|Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 112
China 39
Korea, Republic of 19
France 10
Germany 8
Japan 6
NA 6
United Kingdom 6
Denmark 5
Canada 4
Netherlands 4
United States|France 4
Belgium 3
Switzerland 3
Thailand 3
Hong Kong 2
India 2
Italy 2
Poland 2
Taiwan 2
Australia 1
Australia|Austria|Denmark|Germany|Netherlands|United Kingdom 1
Belgium|United Kingdom 1
China|Korea, Republic of|Taiwan 1
France|Germany|Norway|United Kingdom 1
Israel 1
Italy|Netherlands|Slovakia|Spain 1
Japan|Spain 1
Korea, Republic of|Singapore|Taiwan 1
Mexico 1
Mongolia 1
Netherlands|Spain|Switzerland 1
Spain 1
Sweden 1
Thailand|United States|Australia|Belgium|Canada|France|Italy|Korea, Republic of|Spain|Taiwan 1
United States|Argentina|Australia|Chile|Japan|Korea, Republic of|Poland|Spain|Taiwan 1
United States|Australia|Belgium|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Poland|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|France|Italy|Netherlands|Spain|United Kingdom 1
United States|Australia|France|Hong Kong|Japan|Korea, Republic of|Netherlands|Spain|Taiwan|United Kingdom 1
United States|Australia|France|Korea, Republic of|Spain|United Kingdom 1
United States|Austria 1
United States|Austria|Belgium|Denmark|Finland|France|Germany|Ireland|Israel|Italy|Japan|Netherlands|Norway|Spain|Sweden|Switzerland|United Kingdom 1
United States|Belgium 1
United States|Belgium|Canada|France|Germany|Ireland|Italy|Korea, Republic of|Spain|Switzerland|United Kingdom 1
United States|Belgium|Denmark|Finland|France|Germany|Italy|Norway|Poland|Spain|Sweden 1
United States|Belgium|France|Germany|Israel|Italy|Japan|Korea, Republic of|Spain|Taiwan|Thailand|United Kingdom 1
United States|Belgium|Germany|Italy|Korea, Republic of|Russian Federation|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
United States|Canada 1
United States|China 1
United States|China|France|Italy|Japan|Korea, Republic of|Spain|Taiwan|United Kingdom 1
United States|Denmark 1
United States|Denmark|France|Spain 1
United States|France|Italy|Korea, Republic of|Spain|United Kingdom 1
United States|Germany 1
United States|Italy 1
United States|Korea, Republic of|Taiwan 1
United States|Netherlands|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 161
2 21
3 15
4 3
5 5
6 6
7 9
8 4
9 2
10 1
11 4
12 4
13 1
15 1
16 4
17 2
19 2
20 2
21 1
23 1
25 2
31 1
32 1
33 1
34 2
35 1
36 1
37 1
41 2
42 1
43 1
46 1
49 1
53 1
64 1
68 1
73 1
112 1
120 1
141 1
145 1
154 1
251 1
295 1
333 1
620 1
938 1

Phase

Phase Study_Count
Phase 2 115
N/A 49
Phase 1 49
Phase 1/Phase 2 30
Phase 3 19
Phase 4 8
Phase 2/Phase 3 7
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 135
2 95
3 15
4 8
5 4
7 1
9 1
10 1
NA 19

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 18 5.0000 1.00000 9.00 4.00000 34.0000 43.0000 30.000
1st Qu. 20 46.7500 20.75000 19.75 30.00000 60.0000 158.5000 38.500
Median 22 67.0000 42.50000 66.00 50.00000 89.0000 240.0000 56.500
Mean 22 111.6875 62.41667 89.50 73.42857 195.1429 290.8421 102.625
3rd Qu. 24 122.5000 89.25000 112.25 88.50000 305.5000 408.0000 99.000
Max. 26 667.0000 260.00000 386.00 818.00000 512.0000 781.0000 400.000

Trial Group Type

group_type Group_Count
Experimental 343
Active Comparator 62
Other 20
NA 19
No Intervention 11
Placebo Comparator 10
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 144
Parallel Assignment 106
Sequential Assignment 13
NA 13
Crossover Assignment 2
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 251
Diagnostic 10
Supportive Care 8
Prevention 6
Other 2
Health Services Research 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 11
NA 4
France 2
Germany 2
China 1
Croatia 1
Denmark 1
Greece 1
Japan 1
Romania 1
Sweden 1
Taiwan 1
United States|Egypt|Germany|Peru|Singapore 1
United States|France|Germany 1
United States|France|Italy 1
United States|Italy 1

Sites per Study

Site_count Study_Count
1 26
2 1
5 1
6 3

Enrollment Metrics

Measure Observational
Min 10.0000
1st Qu 99.5000
Median 130.0000
Mean 533.6129
3rd Qu 208.0000
Max 10000.0000

Observation Model

observational_model Study_Count
Cohort 16
Case-Only 5
Case-Control 4
NA 3
Case Control 2
Other 1

Time Perspective

time_perspective Study_Count
Prospective 18
Retrospective 10
Cross-Sectional 2
NA 1

Registries

Studies by Country

Country Study_Count
United States 4
China 1
Italy 1
Korea, Republic of 1

Sites per Study

Site_count Study_Count
1 7

Enrollment Metrics

Measure Registries
Min 10.000
1st Qu 70.000
Median 1000.000
Mean 1807.143
3rd Qu 3250.000
Max 5000.000

Registry Model

observational_model Study_Count
Cohort 4
Other 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 6
Other 1

Follow-up

target_duration Study_Count
1 Year 1
100 Years 1
12 Months 1
2 Years 1
20 Years 1
3 Years 1
36 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04440943 A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT04440943 Recruiting Celldex Therapeutics 2022-03-31
NCT04430842 Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S https://ClinicalTrials.gov/show/NCT04430842 Recruiting Quadriga Biosciences, Inc. 2021-09-30
NCT04137289 A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT04137289 Recruiting Boehringer Ingelheim 2023-04-04
NCT03829436 TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers https://ClinicalTrials.gov/show/NCT03829436 Recruiting Tempest Therapeutics 2022-02-18
NCT03377179 A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03377179 Recruiting RedHill Biopharma Limited 2022-12-31
NCT03368963 TAS102 in Combination With NAL-IRI in Advanced GI Cancers https://ClinicalTrials.gov/show/NCT03368963 Recruiting Emory University 2021-11-28
NCT03364530 Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03364530 Recruiting University Hospital, Montpellier 2022-06-30
NCT03820310 Clinical Trial of Autologous Tcm Immunotherapy in ICC https://ClinicalTrials.gov/show/NCT03820310 Recruiting Newish Technology (Beijing) Co., Ltd. 2021-04-30
NCT03345303 Bortezomib in Intrahepatic Cholangiocellular Carcinoma https://ClinicalTrials.gov/show/NCT03345303 Recruiting Eastern Hepatobiliary Surgery Hospital 2020-12-31
NCT03339843 Multiorgan Metabolic Imaging Response Assessment of Abemaciclib https://ClinicalTrials.gov/show/NCT03339843 Recruiting Jules Bordet Institute 2021-10-15
NCT03338062 A Pilot Study to Assess Theragnostically Planned Liver Radiation With Functional DVH Analysis to Optimize Individualized Radiation Therapy https://ClinicalTrials.gov/show/NCT03338062 Completed Indiana University 2019-09-02
NCT03278106 TAS-102 in Treating Advanced Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT03278106 Active, not recruiting Mayo Clinic 2018-11-30
NCT03267966 Margin Status After Pancreaticoduodenectomy for Cancer https://ClinicalTrials.gov/show/NCT03267966 Completed Campus Bio-Medico University 2015-06-30
NCT03257761 Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT03257761 Recruiting University of Southern California 2021-02-07
NCT03251443 A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03251443 Completed Peking Union Medical College Hospital 2019-03-08
NCT03250273 A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03250273 Recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2020-11-30
NCT03230318 Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03230318 Recruiting Basilea Pharmaceutica 2020-07-31
NCT03212274 Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations https://ClinicalTrials.gov/show/NCT03212274 Recruiting National Cancer Institute (NCI) 2020-07-31
NCT03207347 A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) https://ClinicalTrials.gov/show/NCT03207347 Recruiting University of Florida 2021-12-31
NCT03201458 Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT03201458 Active, not recruiting National Cancer Institute (NCI) 2020-06-30
NCT03150615 Enteral Nutrition After Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT03150615 Completed Nanjing Medical University 2017-12-31
NCT03149549 PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors https://ClinicalTrials.gov/show/NCT03149549 Recruiting CytomX Therapeutics 2019-12-31
NCT03144661 An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies https://ClinicalTrials.gov/show/NCT03144661 Recruiting Incyte Corporation 2021-02-28
NCT03139487 A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03139487 Recruiting Asan Medical Center 2021-09-30
NCT03111732 Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) https://ClinicalTrials.gov/show/NCT03111732 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT03086993 Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03086993 Recruiting Delcath Systems Inc. 2023-01-31
NCT03079427 Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03079427 Recruiting Asan Medical Center 2021-04-30
NCT03058289 A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 https://ClinicalTrials.gov/show/NCT03058289 Recruiting Intensity Therapeutics, Inc. 2022-07-31
NCT03043547 Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies https://ClinicalTrials.gov/show/NCT03043547 Recruiting AIO-Studien-gGmbH 2021-01-31
NCT03042182 Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03042182 Recruiting Immunitor LLC 2020-02-20
NCT03027284 A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT03027284 Completed Eli Lilly and Company 2019-06-20
NCT03003065 Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers https://ClinicalTrials.gov/show/NCT03003065 Recruiting Chinese University of Hong Kong 2022-08-31
NCT02999672 A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors https://ClinicalTrials.gov/show/NCT02999672 Completed Hoffmann-La Roche 2018-04-10
NCT02990481 A Study of TRK-950 in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02990481 Recruiting Toray Industries, Inc 2021-03-31
NCT02989857 Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) https://ClinicalTrials.gov/show/NCT02989857 Active, not recruiting Agios Pharmaceuticals, Inc. 2019-01-31
NCT02958059 Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient https://ClinicalTrials.gov/show/NCT02958059 Recruiting Yonsei University 2020-08-31
NCT02924376 Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202) https://ClinicalTrials.gov/show/NCT02924376 Active, not recruiting Incyte Corporation 2020-11-12
NCT02878473 Liver Transplantation for Early Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02878473 Recruiting University Health Network, Toronto 2026-01-31
NCT02853474 Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy https://ClinicalTrials.gov/show/NCT02853474 Recruiting Centre Oscar Lambret 2021-10-31
NCT02841800 Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis https://ClinicalTrials.gov/show/NCT02841800 Completed National Taiwan University Hospital 2018-08-30
NCT02821754 A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) https://ClinicalTrials.gov/show/NCT02821754 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02807181 SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02807181 Active, not recruiting Sirtex Medical 2021-06-30
NCT02784795 A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT02784795 Completed Eli Lilly and Company 2018-08-09
NCT02773485 Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02773485 Recruiting Tata Memorial Hospital 2022-06-30
NCT02757859 High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02757859 Recruiting Thomas Jefferson University 2020-08-31
NCT02757391 CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT02757391 Active, not recruiting M.D. Anderson Cancer Center 2024-08-01
NCT02699606 A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02699606 Recruiting Janssen Research & Development, LLC 2020-08-31
NCT02683538 Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies https://ClinicalTrials.gov/show/NCT02683538 Completed Seoul National University Hospital 2013-07-31
NCT02649712 Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction https://ClinicalTrials.gov/show/NCT02649712 Completed Xuzhou Central Hospital 2018-10-31
NCT02646514 Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study https://ClinicalTrials.gov/show/NCT02646514 Recruiting Yonsei University 2019-09-30
NCT02626312 Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function https://ClinicalTrials.gov/show/NCT02626312 Recruiting M.D. Anderson Cancer Center 2022-02-28
NCT02609958 ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy https://ClinicalTrials.gov/show/NCT02609958 Completed Aslan Pharmaceuticals 2017-07-07
NCT02592538 Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02592538 Completed First People’s Hospital of Hangzhou 2018-08-31
NCT02591030 Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours https://ClinicalTrials.gov/show/NCT02591030 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2023-09-30
NCT02585856 Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02585856 Completed First People’s Hospital of Hangzhou 2018-08-31
NCT02631590 Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02631590 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2019-11-23
NCT02232932 Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02232932 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2021-09-30
NCT04298021 DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04298021 Recruiting Seoul National University Hospital 2021-03-31
NCT04298008 AZD6738 Plus Durvalumab in Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04298008 Recruiting Seoul National University Hospital 2021-03-31
NCT04034238 Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors https://ClinicalTrials.gov/show/NCT04034238 Recruiting National Institutes of Health Clinical Center (CC) 2022-12-01
NCT02520141 Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02520141 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT02512692 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02512692 Recruiting Medical University of South Carolina 2020-08-31
NCT02496741 Metformin And Chloroquine in IDH1/2-mutated Solid Tumors https://ClinicalTrials.gov/show/NCT02496741 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2019-11-18
NCT02495896 Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT02495896 Active, not recruiting University of Southern California 2020-02-28
NCT02482454 Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02482454 Active, not recruiting The First People’s Hospital of Changzhou 2030-07-31
NCT02468076 Radiofrequency Ablation for Biliopancreatic Malignancy https://ClinicalTrials.gov/show/NCT02468076 Completed Universitaire Ziekenhuizen Leuven 2016-03-31
NCT02456714 Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02456714 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-10-01
NCT02428855 Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02428855 Completed Massachusetts General Hospital 2018-02-28
NCT02393248 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) https://ClinicalTrials.gov/show/NCT02393248 Recruiting Incyte Corporation 2020-07-31
NCT02392637 Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers https://ClinicalTrials.gov/show/NCT02392637 Active, not recruiting M.D. Anderson Cancer Center 2020-04-30
NCT02375880 Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder https://ClinicalTrials.gov/show/NCT02375880 Completed Leap Therapeutics, Inc. 2018-07-31
NCT02351765 ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT02351765 Completed The Christie NHS Foundation Trust 2019-03-31
NCT02333188 Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02333188 Completed University of Chicago 2017-12-31
NCT02273739 Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation https://ClinicalTrials.gov/show/NCT02273739 Completed Celgene 2016-06-30
NCT02232633 A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer https://ClinicalTrials.gov/show/NCT02232633 Active, not recruiting Boston Biomedical, Inc 2019-02-19
NCT02027311 Etomidate vs. Midazolam for Sedation During ERCP https://ClinicalTrials.gov/show/NCT02027311 Completed Cheju Halla General Hospital 2013-08-31
NCT02181634 Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02181634 Completed PrECOG, LLC. 2016-09-24
NCT02167711 Treatment for Bile Duct Cancer in the Liver https://ClinicalTrials.gov/show/NCT02167711 Active, not recruiting Chinese University of Hong Kong 2021-12-31
NCT02162914 Regorafenib Versus Placebo to Treat Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02162914 Active, not recruiting Erasme University Hospital 2019-03-31
NCT02150967 A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02150967 Recruiting QED Therapeutics, Inc. 2022-03-31
NCT02128282 Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02128282 Recruiting Senhwa Biosciences, Inc. 2021-08-31
NCT02108145 Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02108145 Recruiting Fourth Military Medical University 2021-12-31
NCT02088775 PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer https://ClinicalTrials.gov/show/NCT02088775 Active, not recruiting Fox Chase Cancer Center 2016-09-08
NCT02081131 Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT) https://ClinicalTrials.gov/show/NCT02081131 Completed GEM Hospital & Research Center 2015-09-30
NCT02073994 Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation https://ClinicalTrials.gov/show/NCT02073994 Active, not recruiting Agios Pharmaceuticals, Inc. 2021-06-30
NCT01313377 Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery https://ClinicalTrials.gov/show/NCT01313377 Completed UNICANCER 2016-06-30
NCT01290536 Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases https://ClinicalTrials.gov/show/NCT01290536 Completed University of California, San Francisco 2013-10-31
NCT02053376 A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy https://ClinicalTrials.gov/show/NCT02053376 Completed University of Pittsburgh 2018-01-07
NCT02052778 A Study of TAS-120 in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02052778 Active, not recruiting Taiho Oncology, Inc. 2019-12-31
NCT02042443 Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02042443 Completed National Cancer Institute (NCI) 2017-01-31
NCT02028845 Loop-tipped Guidewire in Selective Biliary Cannulation https://ClinicalTrials.gov/show/NCT02028845 Completed Ajou University School of Medicine 2015-12-31
NCT04256980 Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement https://ClinicalTrials.gov/show/NCT04256980 Recruiting Innovent Biologics (Suzhou) Co. Ltd. 2021-04-30
NCT03329950 A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT03329950 Recruiting Celldex Therapeutics 2021-08-31
NCT01963325 S-1 in Combination With Abraxane in Treating Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01963325 Completed Sun Yat-sen University 2017-12-31
NCT01954745 Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01954745 Completed Massachusetts General Hospital 2015-06-30
NCT01938729 Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01938729 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-09-30
NCT01926236 Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT01926236 Completed The Christie NHS Foundation Trust 2018-01-05
NCT01912053 Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01912053 Completed Center Eugene Marquis 2016-12-31
NCT01900158 A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas https://ClinicalTrials.gov/show/NCT01900158 Completed PCI Biotech AS 2019-02-28
NCT01888302 Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery https://ClinicalTrials.gov/show/NCT01888302 Completed Mayo Clinic 2016-06-30
NCT01868490 The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells https://ClinicalTrials.gov/show/NCT01868490 Recruiting Siriraj Hospital 2020-01-30
NCT01862315 Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) https://ClinicalTrials.gov/show/NCT01862315 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-05-31
NCT01766219 CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01766219 Completed Wake Forest University Health Sciences 2018-04-30
NCT01752920 Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations https://ClinicalTrials.gov/show/NCT01752920 Completed Basilea Pharmaceutica 2018-09-25
NCT01718327 A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01718327 Completed GERCOR - Multidisciplinary Oncology Cooperative Group 2016-11-17
NCT01692704 Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy https://ClinicalTrials.gov/show/NCT01692704 Completed University of Zurich 2016-03-31
NCT01673802 The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01673802 Completed University of Alabama at Birmingham 2014-01-31
NCT01673269 Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD https://ClinicalTrials.gov/show/NCT01673269 Completed Texas Tech University Health Sciences Center, El Paso 2013-10-31
NCT01668134 Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01668134 Completed Washington University School of Medicine 2014-08-30
NCT01648023 Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin https://ClinicalTrials.gov/show/NCT01648023 Recruiting University of Louisville 2020-07-31
NCT01643499 Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT01643499 Completed University of Chicago 2016-08-28
NCT01595217 MRCP Diagnoses EHCC Better When Combined DWI https://ClinicalTrials.gov/show/NCT01595217 Completed China Medical University, China 2013-03-31
NCT01534637 Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer https://ClinicalTrials.gov/show/NCT01534637 Completed Wake Forest University Health Sciences 2009-12-31
NCT01525069 Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01525069 Active, not recruiting Washington University School of Medicine 2018-08-08
NCT01470443 Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma https://ClinicalTrials.gov/show/NCT01470443 Active, not recruiting Samsung Medical Center 2016-12-31
NCT01438554 Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01438554 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2016-04-30
NCT01347333 Stereotactic Body Radiotherapy for Liver Tumors https://ClinicalTrials.gov/show/NCT01347333 Completed Mercy Research 2016-09-30
NCT01320254 PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) https://ClinicalTrials.gov/show/NCT01320254 Completed Hannover Medical School 2016-09-12
NCT01320241 Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture https://ClinicalTrials.gov/show/NCT01320241 Completed Southeast University, China 2012-03-31
NCT04404647 Irreversible Electroporation of Unresectable Liver Tumors https://ClinicalTrials.gov/show/NCT04404647 Recruiting Aalborg University Hospital 2025-03-30
NCT04400357 Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors https://ClinicalTrials.gov/show/NCT04400357 Recruiting Ruijin Hospital 2021-05-07
NCT04378023 Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study. https://ClinicalTrials.gov/show/NCT04378023 Recruiting Hospital Vall d’Hebron 2025-06-01
NCT04361331 Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04361331 Recruiting Shanghai Zhongshan Hospital 2020-12-06
NCT04337333 Two-in-one Covered and Uncovered Metal Stent https://ClinicalTrials.gov/show/NCT04337333 Recruiting Ajou University School of Medicine 2020-12-31
NCT04333927 Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer https://ClinicalTrials.gov/show/NCT04333927 Active, not recruiting Sun Yat-sen University 2024-06-30
NCT04316078 A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT04316078 Recruiting Sheba Medical Center 2020-07-01
NCT04308174 Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04308174 Recruiting Asan Medical Center 2021-09-30
NCT04306367 Study of Pembrolizumab and Olaparib in Bile Duct Cancer https://ClinicalTrials.gov/show/NCT04306367 Recruiting Georgetown University 2021-12-01
NCT04305288 Chemotherapy FOLFIRINOX in Advanced or Recurrent Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04305288 Recruiting Shanghai Jiao Tong University School of Medicine 2020-12-31
NCT04301999 Clinical Effect and Safety of PDT and RFA for Unresectable EHCC https://ClinicalTrials.gov/show/NCT04301999 Recruiting First People’s Hospital of Hangzhou 2020-06-01
NCT04299581 Cryoablation Combined With Anti-PD-1 Antibody in Patients With Advanced Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04299581 Recruiting Fudan University 2022-05-10
NCT04295317 PD-1 Antibody (SHR-1210) Plus Apatinib and Capecitabine in Patients With Intrahepatic Cholangiocarcinoma After Surgery https://ClinicalTrials.gov/show/NCT04295317 Recruiting Shanghai Zhongshan Hospital 2021-12-31
NCT04276090 Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04276090 Recruiting University of Kentucky 2023-05-01
NCT04264260 Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment https://ClinicalTrials.gov/show/NCT04264260 Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital 2022-07-31
NCT04238715 A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion https://ClinicalTrials.gov/show/NCT04238715 Recruiting Eisai Inc. 2022-06-30
NCT04238637 Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC) https://ClinicalTrials.gov/show/NCT04238637 Recruiting Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 2023-12-31
NCT04233567 Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations https://ClinicalTrials.gov/show/NCT04233567 Recruiting Ohio State University Comprehensive Cancer Center 2022-12-31
NCT04157985 Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04157985 Recruiting University of Pittsburgh 2021-10-31
NCT04149691 Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies https://ClinicalTrials.gov/show/NCT04149691 Recruiting Celon Pharma SA 2020-07-31
NCT04099888 PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer https://ClinicalTrials.gov/show/NCT04099888 Recruiting PCI Biotech AS 2023-07-31
NCT04078230 Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04078230 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2025-12-31
NCT04077372 Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers https://ClinicalTrials.gov/show/NCT04077372 Recruiting Stanford University 2020-09-30
NCT04076761 Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04076761 Recruiting Sunnybrook Health Sciences Centre 2021-09-30
NCT04072445 Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04072445 Recruiting Mayo Clinic 2021-05-15
NCT04068194 Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies https://ClinicalTrials.gov/show/NCT04068194 Recruiting National Cancer Institute (NCI) 2022-12-03
NCT04066491 Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) https://ClinicalTrials.gov/show/NCT04066491 Recruiting EMD Serono 2022-11-24
NCT04037007 Efficacy of Fistulotomy for Biliary Cannulation https://ClinicalTrials.gov/show/NCT04037007 Recruiting Coordinación de Investigación en Salud, Mexico 2020-03-03
NCT03996408 Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03996408 Recruiting Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2020-12-31
NCT03982680 Toripalimab Combined With Gemcitabine/5–fluoropyrimidine for Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03982680 Recruiting Jiangmen Central Hospital 2021-05-30
NCT03951597 Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03951597 Active, not recruiting Shanghai Zhongshan Hospital 2020-01-10
NCT03943043 Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT03943043 Recruiting Istituto Clinico Humanitas 2020-05-01
NCT03942328 Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer https://ClinicalTrials.gov/show/NCT03942328 Recruiting Mayo Clinic 2022-05-01
NCT03907852 Phase 1/2 Trial of TC-210 T Cells in Patients With Advanced Mesothelin-Expressing Cancer https://ClinicalTrials.gov/show/NCT03907852 Recruiting TCR2 Therapeutics 2021-06-30
NCT03898895 COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable inTrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03898895 Recruiting Sun Yat-sen University 2024-11-30
NCT03895970 Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors https://ClinicalTrials.gov/show/NCT03895970 Recruiting Peking Union Medical College Hospital 2020-04-01
NCT03878095 Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors https://ClinicalTrials.gov/show/NCT03878095 Recruiting National Cancer Institute (NCI) 2023-03-01
NCT03872947 A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03872947 Recruiting Toray Industries, Inc 2021-04-30
NCT03852836 Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images https://ClinicalTrials.gov/show/NCT03852836 Recruiting IHU Strasbourg 2021-02-28
NCT03849469 A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03849469 Recruiting Xencor, Inc. 2026-09-30
NCT03833661 M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) https://ClinicalTrials.gov/show/NCT03833661 Active, not recruiting EMD Serono 2020-11-09
NCT03801915 Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers https://ClinicalTrials.gov/show/NCT03801915 Recruiting National Institutes of Health Clinical Center (CC) 2023-12-31
NCT03801083 Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT03801083 Recruiting University of Pittsburgh 2021-01-31
NCT03796819 Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03796819 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-12-31
NCT03792048 Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple’s Procedure https://ClinicalTrials.gov/show/NCT03792048 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-01-31
NCT03781934 A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations https://ClinicalTrials.gov/show/NCT03781934 Recruiting Medivir 2021-12-31
NCT03779035 Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection https://ClinicalTrials.gov/show/NCT03779035 Recruiting Tianjin Medical University Cancer Institute and Hospital 2020-12-31
NCT03773302 Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations https://ClinicalTrials.gov/show/NCT03773302 Recruiting QED Therapeutics, Inc. 2023-09-30
NCT03772132 Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT03772132 Recruiting Shanghai Jiao Tong University School of Medicine 2020-12-31
NCT03771846 HAIC Versus Systemic Chemotherapy for Unresectable ICC https://ClinicalTrials.gov/show/NCT03771846 Recruiting Sun Yat-sen University 2022-08-01
NCT03769753 Trial of IRE in Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03769753 Recruiting Memorial Sloan Kettering Cancer Center 2020-12-31
NCT03768414 Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT03768414 Recruiting Southwest Oncology Group 2024-01-01
NCT03768375 Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT03768375 Recruiting Shanghai Jiao Tong University School of Medicine 2020-12-30
NCT03763214 PTFE Stents for Treatment of Malignant Biliary Strictures https://ClinicalTrials.gov/show/NCT03763214 Recruiting Johann Wolfgang Goethe University Hospital 2020-03-31
NCT03708445 Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer https://ClinicalTrials.gov/show/NCT03708445 Completed Gangnam Severance Hospital 2020-01-22
NCT03693807 A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03693807 Recruiting Memorial Sloan Kettering Cancer Center 2020-09-30
NCT03684811 A Study of FT 2102 in Participants With Advanced Solid Tumors and Gliomas With an IDH1 Mutation https://ClinicalTrials.gov/show/NCT03684811 Active, not recruiting Forma Therapeutics, Inc. 2021-09-01
NCT03679338 Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer https://ClinicalTrials.gov/show/NCT03679338 Recruiting Institut Paoli-Calmettes 2020-11-30
NCT03656536 A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302) https://ClinicalTrials.gov/show/NCT03656536 Recruiting Incyte Corporation 2023-10-31
NCT03633773 Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03633773 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2023-08-31
NCT03620292 Fluorescence Image Guided Surgery in Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03620292 Recruiting University Medical Center Groningen 2020-04-01
NCT03613168 Trastuzumab in HER2-positive Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT03613168 Recruiting Asan Medical Center 2020-09-01
NCT03603834 Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03603834 Recruiting Khon Kaen University 2023-08-31
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene https://ClinicalTrials.gov/show/NCT03602079 Recruiting Klus Pharma Inc. 2020-10-31
NCT03579771 Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer https://ClinicalTrials.gov/show/NCT03579771 Recruiting Emory University 2021-09-30
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03517488 Recruiting Xencor, Inc. 2020-12-31
NCT03475966 Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program https://ClinicalTrials.gov/show/NCT03475966 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2019-12-31
NCT03473574 Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients https://ClinicalTrials.gov/show/NCT03473574 Recruiting AIO-Studien-gGmbH 2021-09-30
NCT03447691 Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery https://ClinicalTrials.gov/show/NCT03447691 Recruiting Yonsei University 2022-08-28
NCT03422679 Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies https://ClinicalTrials.gov/show/NCT03422679 Recruiting Cellestia Biotech AG 2021-06-30
NCT01267344 A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC https://ClinicalTrials.gov/show/NCT01267344 Completed National Health Research Institutes, Taiwan 2013-12-31
NCT01256047 Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy https://ClinicalTrials.gov/show/NCT01256047 Completed Chiba University 2014-03-31
NCT01256034 Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT01256034 Completed Chiba University 2012-03-31
NCT01253148 Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01253148 Completed H. Lee Moffitt Cancer Center and Research Institute 2015-08-31
NCT01242605 ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT01242605 Completed University College, London 2013-03-31
NCT01206049 Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations https://ClinicalTrials.gov/show/NCT01206049 Completed Vejle Hospital 2016-03-31
NCT01153750 Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct https://ClinicalTrials.gov/show/NCT01153750 Completed University Hospital Dresden 2010-03-31
NCT01145248 Comparison of Biliary Forceps Biopsy and Brush Cytology https://ClinicalTrials.gov/show/NCT01145248 Completed University of Ulm 2009-07-31
NCT01134276 Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers https://ClinicalTrials.gov/show/NCT01134276 Completed Seoul National University Hospital 2013-05-31
NCT01093222 Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01093222 Completed National Cancer Institute (NCI) 2012-09-30
NCT01073839 Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. https://ClinicalTrials.gov/show/NCT01073839 Completed University of Zurich 2015-08-31
NCT01043172 A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection https://ClinicalTrials.gov/show/NCT01043172 Completed National Cancer Center, Korea 2016-12-31
NCT01007552 A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts https://ClinicalTrials.gov/show/NCT01007552 Completed Roswell Park Cancer Institute 2015-05-31
NCT00987766 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer https://ClinicalTrials.gov/show/NCT00987766 Completed Vanderbilt-Ingram Cancer Center 2013-07-31
NCT00976898 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00976898 Completed Massachusetts General Hospital 2017-03-31
NCT00955149 Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) https://ClinicalTrials.gov/show/NCT00955149 Completed Mayo Clinic 2013-04-30
NCT00949949 Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy https://ClinicalTrials.gov/show/NCT00949949 Completed Mayo Clinic 2014-07-31
NCT00948935 Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma https://ClinicalTrials.gov/show/NCT00948935 Completed Abramson Cancer Center of the University of Pennsylvania 2014-09-30
NCT00919061 Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy https://ClinicalTrials.gov/show/NCT00919061 Completed Memorial Sloan Kettering Cancer Center 2014-03-31
NCT00869635 S-1 and Photodynamic Therapy in Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00869635 Completed Asan Medical Center 2013-07-31
NCT00858429 Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases https://ClinicalTrials.gov/show/NCT00858429 Completed Northwestern University 2014-03-19
NCT03774589 Bilioenteric Anastomosis by Magnetic Compressive Technique https://ClinicalTrials.gov/show/NCT03774589 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-01-31
NCT04413734 Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04413734 Recruiting Zhejiang University 2022-04-22
NCT04386772 Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04386772 Recruiting Eastern Hepatobiliary Surgery Hospital 2022-12-31
NCT03734926 A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03734926 Recruiting Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2020-10-20
NCT02881554 Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery https://ClinicalTrials.gov/show/NCT02881554 Recruiting University of Washington 2022-06-01
NCT01825603 ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01825603 Completed University of Nebraska 2017-06-30
NCT01642875 Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy https://ClinicalTrials.gov/show/NCT01642875 Recruiting Medical University of Warsaw 2019-12-31
NCT02568267 Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) https://ClinicalTrials.gov/show/NCT02568267 Recruiting Hoffmann-La Roche 2022-12-01
NCT04175912 Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver https://ClinicalTrials.gov/show/NCT04175912 Recruiting National Cancer Institute (NCI) 2022-10-01
NCT03940378 Treatment of Advanced Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03940378 Recruiting The First Affiliated Hospital of Zhengzhou University 2023-02-01
NCT03104569 Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03104569 Recruiting Hepatopancreatobiliary Surgery Institute of Gansu Province 2021-04-01
NCT03307538 Stereotactic Body Radiation Therapy for Unresectable Perihilar Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03307538 Recruiting Erasmus Medical Center 2018-11-30
NCT02836847 Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT02836847 Recruiting Shanghai Jiao Tong University School of Medicine 2019-12-31
NCT02659852 A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction https://ClinicalTrials.gov/show/NCT02659852 Recruiting Yonsei University 2020-01-31
NCT03644173 Personal Resilience Empowerment Program Study https://ClinicalTrials.gov/show/NCT03644173 Active, not recruiting Hackensack Meridian Health 2020-09-30
NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors https://ClinicalTrials.gov/show/NCT02834013 Recruiting National Cancer Institute (NCI) 2021-08-31
NCT02170090 Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT02170090 Recruiting Universitätsklinikum Hamburg-Eppendorf 2021-04-30
NCT00789958 S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct https://ClinicalTrials.gov/show/NCT00789958 Completed Southwest Oncology Group 2014-12-31
NCT00779454 Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00779454 Completed Vejle Hospital 2016-03-31
NCT00753675 Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00753675 Completed Sanofi 2012-09-30
NCT00733200 Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection? https://ClinicalTrials.gov/show/NCT00733200 Completed Huazhong University of Science and Technology NA
NCT00721175 Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00721175 Completed Khon Kaen University 2010-04-30
NCT00660699 A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers https://ClinicalTrials.gov/show/NCT00660699 Completed Washington University School of Medicine 2010-09-30
NCT00660140 Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00660140 Completed Washington University School of Medicine 2007-01-31
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00654160 Completed Mayo Clinic 2010-11-30
NCT00639314 Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT00639314 Completed Wakayama Medical University 2009-05-31
NCT00628186 Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT00628186 Completed Wakayama Medical University 2007-08-31
NCT00553332 Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00553332 Completed National Cancer Institute (NCI) 2013-01-31
NCT00544193 Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00544193 Completed City of Hope Medical Center 2012-08-31
NCT00513539 Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00513539 Completed University College, London 2009-12-31
NCT00486356 Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00486356 Completed University of Nebraska 2010-01-31
NCT00465023 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases https://ClinicalTrials.gov/show/NCT00465023 Completed Massachusetts General Hospital 2013-09-30
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00363584 Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00363584 Completed National Cancer Institute (NCI) 2013-08-31
NCT00356889 Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors https://ClinicalTrials.gov/show/NCT00356889 Completed National Cancer Institute (NCI) 2008-10-31
NCT00350961 Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00350961 Completed Rigshospitalet, Denmark NA
NCT00350753 Avastin and Tarceva for Upper Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT00350753 Completed Rigshospitalet, Denmark 2009-06-30
NCT00338988 Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00338988 Completed M.D. Anderson Cancer Center 2009-05-31
NCT00304135 Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00304135 Completed Federation Francophone de Cancerologie Digestive 2012-12-31
NCT00280709 Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction https://ClinicalTrials.gov/show/NCT00280709 Completed University Hospital, Linkoeping 2008-10-31
NCT00266097 Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00266097 Completed UNC Lineberger Comprehensive Cancer Center 2009-03-31
NCT00262769 Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors https://ClinicalTrials.gov/show/NCT00262769 Completed University College, London 2008-08-31
NCT00238212 S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00238212 Completed National Cancer Institute (NCI) 2007-01-31
NCT00230347 Evaluation of Stereotactic Radiosurgery For Liver Malignancies https://ClinicalTrials.gov/show/NCT00230347 Completed Stanford University 2007-01-31
NCT00183846 Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT00183846 Completed University of Southern California 2007-10-31
NCT00168987 Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors https://ClinicalTrials.gov/show/NCT00168987 Completed Charite University, Berlin, Germany 2006-11-30
NCT00107536 Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00107536 Completed National Cancer Institute (NCI) 2009-05-31
NCT00101036 Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00101036 Completed National Cancer Institute (NCI) 2009-01-31
NCT00003557 Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00003557 Completed University of Chicago 2000-06-30
NCT00084942 Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder https://ClinicalTrials.gov/show/NCT00084942 Completed Roswell Park Cancer Institute 2004-05-31
NCT00004604 Biological Therapy in Treating Patients With Metastatic Cancer https://ClinicalTrials.gov/show/NCT00004604 Completed Duke University 2001-06-30
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00003427 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00005938 DX-8951f in Treating Patients With Biliary Cancer https://ClinicalTrials.gov/show/NCT00005938 Completed Daiichi Sankyo, Inc. 2005-04-30
NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer https://ClinicalTrials.gov/show/NCT00019474 Completed Montefiore Medical Center 2000-08-31
NCT00003411 Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer https://ClinicalTrials.gov/show/NCT00003411 Completed University of Pittsburgh 2002-06-30
NCT00003923 Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas https://ClinicalTrials.gov/show/NCT00003923 Completed Memorial Sloan Kettering Cancer Center 2002-02-28
NCT00009893 Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00009893 Completed Alliance for Clinical Trials in Oncology 2005-01-31
NCT00073905 Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00073905 Completed Swiss Group for Clinical Cancer Research 2006-06-30
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00033462 Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00033462 Completed National Cancer Institute (NCI) 2006-11-30
NCT00004910 Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction https://ClinicalTrials.gov/show/NCT00004910 Completed Northwestern University 2003-02-28
NCT00004895 Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00004895 Completed Northwestern University 2002-10-31
NCT00059865 Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00059865 Completed Alliance for Clinical Trials in Oncology 2007-02-28
NCT00033540 S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00033540 Completed Southwest Oncology Group 2008-04-30
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00028496 Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00028496 Completed National Cancer Institute (NCI) 2005-11-30
NCT00021047 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor https://ClinicalTrials.gov/show/NCT00021047 Completed National Institutes of Health Clinical Center (CC) NA
NCT00019513 Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00019513 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041808 Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver https://ClinicalTrials.gov/show/NCT00041808 Completed FeRx NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04385147 Advanced Endoscopy During COVID-19 https://ClinicalTrials.gov/show/NCT04385147 Completed Al-Azhar University 2020-07-01
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study https://ClinicalTrials.gov/show/NCT03405909 Recruiting University Hospital Erlangen 2020-02-29
NCT03320980 RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03320980 Completed Moscow Clinical Scientific Center 2017-09-20
NCT03041662 Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC) https://ClinicalTrials.gov/show/NCT03041662 Completed Karolinska University Hospital 2016-10-31
NCT02893085 Pancreatico-biliary Tumor Mutation Profiling in Bile Samples https://ClinicalTrials.gov/show/NCT02893085 Completed CHU de Reims 2016-10-31
NCT02762721 Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples https://ClinicalTrials.gov/show/NCT02762721 Completed ArQule 2017-04-06
NCT02730611 Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02730611 Completed Assistance Publique - Hôpitaux de Paris 2017-10-31
NCT02156700 Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors https://ClinicalTrials.gov/show/NCT02156700 Completed University Hospital Dubrava 2015-12-31
NCT01773655 Clinical and Histopathologic Characteristics of BAP1 Mutations https://ClinicalTrials.gov/show/NCT01773655 Completed Memorial Sloan Kettering Cancer Center 2020-06-30
NCT02000999 Diagnosis of Bile Duct Strictures https://ClinicalTrials.gov/show/NCT02000999 Completed Washington University School of Medicine 2019-01-02
NCT01915225 Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer https://ClinicalTrials.gov/show/NCT01915225 Recruiting National Institutes of Health Clinical Center (CC) 2027-06-30
NCT01862276 Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01862276 Completed Kansai Hepatobiliary Oncology Group 2014-03-31
NCT04072250 Surgery for Recurrent Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04072250 Completed Chang Gung Memorial Hospital 2018-10-01
NCT03999593 Long-term Morbidity After Surgery for Perihilar Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03999593 Completed University of Liverpool 2017-10-31
NCT03951324 Volumetric Laser Endomicroscopy’s (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study https://ClinicalTrials.gov/show/NCT03951324 Enrolling by invitation Innovative Digestive Health Education and Research Inc 2019-12-31
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT03788655 Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract https://ClinicalTrials.gov/show/NCT03788655 Recruiting Johann Wolfgang Goethe University Hospital 2020-12-31
NCT03563352 Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer https://ClinicalTrials.gov/show/NCT03563352 Recruiting University of Southern California 2020-08-30
NCT03494023 EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice https://ClinicalTrials.gov/show/NCT03494023 Completed Clinical Hospital Colentina 2019-12-31
NCT01213758 Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT https://ClinicalTrials.gov/show/NCT01213758 Completed University of Aarhus 2016-04-30
NCT01135849 B-Receptor Signaling in Cardiomyopathy https://ClinicalTrials.gov/show/NCT01135849 Completed Stanford University 2010-10-31
NCT01135732 Cytological Evaluation of Biliary Epithelium After Endoscopic Sphincterotomy https://ClinicalTrials.gov/show/NCT01135732 Completed University of Athens 2010-06-30
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00836992 Completed Mayo Clinic 2011-09-15
NCT01392274 pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture https://ClinicalTrials.gov/show/NCT01392274 Completed Mauna Kea Technologies 2013-09-30
NCT03178409 Combined HCC-MFCCC https://ClinicalTrials.gov/show/NCT03178409 Completed University of Milan 2014-12-31
NCT03499782 Precise Treatment System of Biliary Malignancies Based on Special Disease Database https://ClinicalTrials.gov/show/NCT03499782 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2021-08-31
NCT00779688 A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers https://ClinicalTrials.gov/show/NCT00779688 Completed Mauna Kea Technologies 2009-09-30
NCT00579865 Quality Of Life in Patients With Malignant Biliary Obstruction https://ClinicalTrials.gov/show/NCT00579865 Completed Memorial Sloan Kettering Cancer Center 2010-01-31
NCT00559598 Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00559598 Completed National Institutes of Health Clinical Center (CC) NA
NCT00320918 Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib https://ClinicalTrials.gov/show/NCT00320918 Completed University of New Mexico 2006-08-31
NCT00301379 Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients https://ClinicalTrials.gov/show/NCT00301379 Recruiting Washington University School of Medicine 2022-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02917759 Liver and Biliary Tumor Tissue Registry https://ClinicalTrials.gov/show/NCT02917759 Recruiting Mayo Clinic 2024-02-29
NCT01920503 International Registry on Cholangiocarcinoma Treatment https://ClinicalTrials.gov/show/NCT01920503 Recruiting International Group of Endovascular Oncology 2019-07-31
NCT04243057 Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study https://ClinicalTrials.gov/show/NCT04243057 Recruiting Beijing Tsinghua Chang Gung Hospital 2022-09-30
NCT03739164 Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) https://ClinicalTrials.gov/show/NCT03739164 Enrolling by invitation Florida Hospital Tampa Bay Division 2024-08-01
NCT03637569 The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer https://ClinicalTrials.gov/show/NCT03637569 Recruiting Samsung Medical Center 2020-04-30
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://ClinicalTrials.gov/show/NCT03452774 Recruiting Massive Bio, Inc. 2021-12-31
NCT03445585 Biobank for Cholestatic Liver Diseases. https://ClinicalTrials.gov/show/NCT03445585 Enrolling by invitation Mayo Clinic 2030-01-31